175 results on '"Rasouliyan L"'
Search Results
2. MSR117 Identifying Economic Insecurity Among Psoriasis Patients Using Natural Language Processing and Unstructured Clinical Notes
3. HSD111 Real-World Treatment Patterns of Ankylosing Spondylitis
4. HSD96 Trends in the Therapeutic Management of Bullous Pemphigoid in the Real-World Setting
5. HSD18 Itch Intensity and Therapeutic Management of Pruritus in the Real-World Setting
6. EPH250 Clinical Characteristics of Generalized Pustular Psoriasis Flares in the Real-World Setting
7. HSD110 Trends in the Therapeutic Management of Localized Scleroderma in the Real-World Setting
8. HSD109 Diabetic Retinopathy Patients at Initiation of Anti-Vascular Endothelial Growth Factor Injection
9. P22 Severity Score Extraction from Unstructured Clinical Notes Using a Disease-Agnostic Natural Language Processing Question-Answering Pipeline
10. Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
11. RWD163 Age-Related Cataract: Patient Characteristics and Real-World Treatment Patterns in the United States
12. HSD116 Bullous Pemphigoid Disease Activity and Initiation of Systemic Therapy in the Real-World Setting
13. HSD22 Wet Age-Related Macular Degeneration: Trends in Real-World Treatment Patterns in the United States
14. RWD64 Identifying Patient-Level Social Determinants of Health in Unstructured Clinical Notes From Electronic Health Records
15. MSR55 Extraction of Ejection Fraction From Clinical Notes Using a Pretrained Albert-for-Question-Answering Model
16. HSD56 Hidradenitis Suppurativa in the Pediatric Population
17. HSD28 Cosmetic Dermatology Product Use in Specialty Dermatology Networks
18. HSD121 Atopic Dermatitis Disease Activity and Initiation of Systemic Therapy in the Real-World Setting
19. MSR55 Detecting Generalized Pustular Psoriasis Exacerbations in Unstructured Clinical Data Using Deep Neural Networks
20. HSD93 Trends in the Use of Biologics for Treatment of Psoriatic Arthritis
21. HSD2 Hidradenitis Suppurativa: Trends in Real-World Treatment Patterns in the United States
22. MSR43 Extracting Severity Markers from Unstructured Clinical Data of Congestive Heart Failure Patients Using a Pretrained Text-to-Text Transfer Transformer Model
23. HSD82 Vitiligo: Trends in Real-World Treatment Patterns in the United States
24. HSD131 Alopecia Areata: Trends in Real-World Treatment Patterns in the United States
25. MSR82 Implementation and Validation of the Use of N-Gram Models for Classifying Social Determinants of Health Status from Real World Unstructured Clinical Notes
26. HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting
27. HSD29 Predicting Psoriasis Area and Severity Index From Physician Global Assessment and Body Surface Area in the Real-World Dermatology Setting
28. HSD2 Switching From Anti-VEGF to Corticosteroid Implant Therapy in Diabetic Macular Edema Patients
29. CO23 Predicting Moderate-to-Severe Plaque Psoriasis From Prescription and Procedure Electronic Health Record Data
30. POSB419 Total Knee Arthroplasty: Do Outcomes Differ By Implant Design in the Real World?
31. POSC236 Atopic Dermatitis: Trends in Real-World Treatment Patterns in Dermatology Specialty Networks
32. PNS89 WORTH the Weight: Evaluation of Weighting Strategies in Unanchored Matching-Adjusted Indirect Comparison
33. PIN59 COVID-19: The Real-World Hospitalized Patient Experience
34. PIN64 Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System
35. PSY13 Relationship between Affected Body Surface Area and Initiation of Systemic Therapy in Psoriasis Patients
36. PIT1 Negative Pressure Wound Therapy for Pressure Ulcer: Effect on Outcomes and Utilization Using Real-World DATA
37. PCR217 Healthcare Resource Utilization Among Hormone Receptor-Positive and Negative Breast Cancer Patients in the Real-World Setting
38. HSD12 Measuring Psoriasis Disease Activity in the Real-World Setting: Relationship between the Physician Global Assessment and Body Surface Area Product and the Psoriasis Area and Severity Index
39. CO36 Keratometry, Intraocular Pressure, and Visual Acuity at the Onset of Ophthalmic Conditions in the Real-World Setting
40. P56 Extraction of Inflammatory Bowel Disease Severity Scores from Unstructured Clinical Notes Using a Retriever-Reader Architecture.
41. RISK FACTORS FOR DEATH BEFORE AGE 18 IN CYSTIC FIBROSIS: 418★
42. IDENTIFICATION AND TREATMENT OF PULMONARY EXACERBATIONS AT HIGHER VS LOWER PERFORMING ESCF SITES: 420★
43. PRACTICE PATTERNS FOR TREATING RESPIRATORY EXACERBATIONS IN CYSTIC FIBROSIS: 440⋆
44. LONGITUDINAL ASSESSMENT OF CHANGES IN HEALTH STATUS AND HEALTH-RELATED QUALITY OF LIFE IN CYSTIC FIBROSIS: 554⋆
45. TRENDS IN THE USE OF ROUTINE THERAPIES IN CYSTIC FIBROSIS: 1995-2005: 487
46. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma
47. PCN434 THE EFFECT MODIFICATION PROBLEM: USING STRATIFIED MATCHING ADJUSTED INDIRECT COMPARISON TO EVADE MISLEADING INTERPRETATIONS OF THE TREATMENT EFFECT
48. PRM223 - THE MISSING DATA PROBLEM: USING PROPENSITY SCORES TO ESTIMATE NON-RANDOMISED TREATMENT EFFECTS WITH MISSING COVARIATE DATA
49. Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study
50. Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years:long-term data from the future 1 and future 2 studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.